Cargando…
Monocyte chemoattractant protein-1 contributes to morphine tolerance in rats with cancer-induced bone pain
Cancer-induced bone pain can severely compromise the life quality of patients, while tolerance limits the use of opioids in the treatment of cancer pain. Monocyte chemoattractant protein-1 (MCP-1) is known to contribute to neuropathic pain. However, the role of spinal MCP-1 in the development of mor...
Autores principales: | Liu, Lei, Gao, Xiu-Juan, Ren, Chun-Guang, Hu, Ji-Hua, Liu, Xian-Wen, Zhang, Ping, Zhang, Zong-Wang, Fu, Zhi-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348680/ https://www.ncbi.nlm.nih.gov/pubmed/28352316 http://dx.doi.org/10.3892/etm.2016.3979 |
Ejemplares similares
-
Co-Administration of nalbuphine to improve morphine tolerance in mice with bone cancer pain
por: Ren, Bingxu, et al.
Publicado: (2023) -
CCL2/Monocyte Chemoattractant Protein 1 and Parathyroid Hormone Action on Bone
por: Siddiqui, Jawed Akhtar, et al.
Publicado: (2017) -
Effects of Electroacupuncture Treatment on Bone Cancer Pain Model with Morphine Tolerance
por: Sima, Lei, et al.
Publicado: (2016) -
Urinary Monocyte Chemoattractant Protein-1 in Patients With Alport Syndrome
por: Kashtan, Clifford, et al.
Publicado: (2022) -
Serum Monocyte Chemoattractant Protein-1 in Pancreatic Cancer
por: Sullivan, Jennifer, et al.
Publicado: (2011)